◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › C › CI

Cigna Corp (CI) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Services · DATA UPDATED 2026-08-30

Cigna Corp (CI) operates in the Health Care Services industry and is headquartered in Bloomfield, United States with about 65,669 employees. Its market capitalization is roughly $73 billion. In the fiscal year ended 2025-12-31, CI reported $275.0B in revenue and $6.0B in net income.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.

Interactive charts & full statements → Open the CI valuation workbench →

CI Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$282.4B	$275.0B	$247.1B	$195.3B	$180.5B	$174.1B	$160.4B	$153.6B	$48.6B	$41.8B	$39.8B	$37.9B	$34.9B	$32.4B	$29.1B	$21.6B	$21.1B	$18.4B	$19.1B	$17.6B	$16.5B
Gross Profit	$32.9B	$26.0B	$26.0B	$25.2B	$23.5B	$23.0B	$24.2B	$25.1B	$16.3B	$14.1B	$13.0B	$12.5B	$11.7B	$32.4B	$29.1B	$21.6B	$21.1B	$18.4B	$19.1B	$17.6B	$16.5B
Gross Margin %	11.7%	9.4%	10.5%	12.9%	13.0%	13.2%	15.1%	16.3%	33.6%	33.7%	32.7%	32.9%	33.4%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Operating Income (EBIT)	$9.8B	$9.1B	$9.4B	$8.5B	$8.4B	$7.9B	$8.2B	$8.1B	$4.2B	$3.9B	$3.1B	$12.4B	$11.6B	$32.4B	$2.9B	$1.9B	$1.8B	$1.9B	$382M	$1.6B	$1.7B
Operating Margin %	3.5%	3.3%	3.8%	4.4%	4.7%	4.6%	5.1%	5.3%	8.6%	9.4%	7.8%	32.6%	33.2%	100.0%	9.9%	8.7%	8.6%	10.3%	2.0%	9.2%	10.5%
Net Income	$6.4B	$6.0B	$3.4B	$5.2B	$6.7B	$5.4B	$8.5B	$5.1B	$2.6B	$2.2B	$1.9B	$2.1B	$2.1B	$1.5B	$1.6B	$1.3B	$1.3B	$1.3B	$292M	$1.1B	$1.2B
Net Margin %	2.3%	2.2%	1.4%	2.6%	3.7%	3.1%	5.3%	3.3%	5.4%	5.3%	4.7%	5.5%	6.0%	4.6%	5.6%	5.8%	6.1%	7.1%	1.5%	6.3%	7.0%
EBITDA	$11.8B	$11.6B	$11.4B	$10.8B	$10.4B	$10.0B	$10.4B	$11.6B	$5.2B	$4.4B	$3.5B	$3.8B	$3.6B	$597M	$560M	$2.5B	$2.3B	$2.3B	$351M	$1.8B	$1.9B
Earnings Per Share (EPS)	$24.15	$22.40	$12.12	$17.39	$21.41	$15.75	$22.96	$13.44	$10.69	$9.17	$7.19	$8.04	$7.83	$5.18	$5.61	$4.59	$4.65	$4.73	$1.05	$3.94	$3.43
Shares Outstanding (M)	264M	266M	283M	297M	313M	341M	368M	380M	247M	244M	260M	261M	269M	285M	290M	274M	275M	275M	279M	283M	337M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CI Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$71.7B	$68.5B	$72.5B	$69.7B	$67.2B	$65.5B	$65.6B	$63.7B
Gross Profit	$15.0B	$6.5B	$5.6B	$5.9B	$7.9B	$6.6B	$6.5B	$6.6B
Gross Margin %	20.9%	9.4%	7.7%	8.5%	11.7%	10.1%	9.8%	10.4%
Operating Income (EBIT)	$2.7B	$2.4B	$2.1B	$2.6B	$2.4B	$2.0B	$2.2B	$2.6B
Operating Margin %	3.7%	3.4%	3.0%	3.7%	3.6%	3.0%	3.3%	4.0%
Net Income	$1.7B	$1.7B	$1.2B	$1.9B	$1.5B	$1.3B	$1.4B	$739M
Net Margin %	2.3%	2.4%	1.7%	2.7%	2.3%	2.0%	2.2%	1.2%
EBITDA	$2.6B	$3.3B	$2.5B	$3.3B	$3.0B	$3.1B	$2.9B	$3.3B
Earnings Per Share (EPS)	$6.29	$6.26	$4.64	$6.97	$5.71	$4.67	$5.13	$2.63
Shares Outstanding (M)	264M	264M	266M	268M	268M	283M	278M	281M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CI Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$10.3B	$9.6B	$10.4B	$11.8B	$8.7B	$7.2B	$10.3B	$9.5B	$3.8B	$4.1B	$4.0B	$2.9B	$2.2B	$719M	$2.4B	$1.5B	$1.7B	$745M	$1.7B	$1.3B	$642M
Capital Expenditures (CapEx)	$1.2B	$1.2B	$1.4B	$1.6B	$1.3B	$1.2B	$1.1B	$1.1B	$528M	$471M	$461M	$510M	$473M	$527M	$408M	$422M	$300M	$307M	$257M	$262M	$136M
Free Cash Flow (FCF)	$9.1B	$8.4B	$9.0B	$10.2B	$7.4B	$6.0B	$9.3B	$8.4B	$3.2B	$3.6B	$3.6B	$2.4B	$1.7B	$192M	$1.9B	$1.1B	$1.4B	$438M	$1.4B	$1.1B	$506M
FCF Margin %	3.2%	3.0%	3.6%	5.2%	4.1%	3.5%	5.8%	5.5%	6.7%	8.6%	8.9%	6.4%	4.8%	0.6%	6.7%	4.9%	6.9%	2.4%	7.3%	6.1%	3.1%
Dividends Paid	$1.6B	$1.6B	$1.6B	$1.4B	$1.4B	$1.3B	$15M	$15M	$24.3B	$1.7B	$0M	$894M	$11M	$11M	$11M	$11M	$11M	$11M	$14M	$11M	$12M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CI Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($421M)	$1.1B	$6.1B	$3.4B	($1.9B)	$1.9B	$5.2B	$46M
Capital Expenditures (CapEx)	$297M	$267M	$322M	$278M	$285M	$327M	$337M	$399M
Free Cash Flow (FCF)	($718M)	$864M	$5.8B	$3.1B	($2.2B)	$1.6B	$4.9B	($353M)
FCF Margin %	-1.0%	1.3%	8.0%	4.5%	-3.2%	2.4%	7.4%	-0.5%
Dividends Paid	$409M	$417M	$396M	$402M	$401M	$412M	$384M	$390M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CI Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$157.1B	$157.9B	$155.9B	$152.8B	$143.9B	$154.9B	$155.5B	$155.8B	$153.2B	$61.8B	$59.4B	$57.1B	$55.9B	$54.3B	$51.0B	$51.0B	$45.7B	$43.0B	$41.4B	$40.1B	$42.4B
Cash & Cash Equivalents	$6.3B	$7.7B	$7.5B	$7.8B	$5.9B	$5.1B	$10.2B	$4.6B	$3.9B	$3.0B	$3.2B	$2.0B	$1.4B	$2.8B	$3.0B	$4.7B	$1.6B	$924M	$1.3B	$2.0B	$1.4B
Total Liabilities	$114.2B	$116.0B	$114.6B	$106.4B	$99.0B	$107.7B	$105.1B	$110.4B	$112.2B	$48.0B	$45.6B	$45.0B	$45.0B	$43.7B	$41.1B	$42.7B	$39.0B	$37.6B	$37.8B	$35.3B	$38.1B
Total Debt (Short + Long-Term)	$31.9B	$31.5B	$32.0B	$30.9B	$31.1B	$33.8B	$33.1B	$37.5B	$42.5B	$5.4B	$5.0B	$5.2B	$5.2B	$5.2B	$5.2B	$5.1B	$2.8B	$2.5B	$2.4B	$1.8B	$1.7B
Total Shareholders' Equity	$42.6B	$41.7B	$41.0B	$46.2B	$44.9B	$47.1B	$50.3B	$45.3B	$41.0B	$13.7B	$13.7B	$12.0B	$10.8B	$10.6B	$9.8B	$8.3B	$6.6B	$5.4B	$3.6B	$4.7B	$4.3B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CI viewer.

CI Metric Deep Dives

Other Companies in Health Care Services

CVS · CVS Health — $114 billion
DGX · Quest Diagnostics — $27 billion
LH · Labcorp — $26 billion
DVA · DaVita — $12 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← CHYM All “C” companies CI2G →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.